FDA Drug Recalls

Recalls / Class II

Class IID-1055-2022

Product

Ibuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61

Brand name
Ibuprofen
Generic name
Ibuprofen
Active ingredient
Ibuprofen
Route
Oral
NDCs
0904-5853, 0904-5854, 0904-5855
FDA application
ANDA075682
Affected lot / code info
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.

Why it was recalled

cGMP deviations: Temperature abuse

Recalling firm

Firm
Mckesson Medical-Surgical Inc. Corporate Office
Manufacturer
Major Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
9954 Maryland Drive, Deep Run Iii Ste. 4000, Richmond, Virginia 23233

Distribution

Quantity
1 carton/100 blisters per carton
Distribution pattern
USA nationwide.

Timeline

Recall initiated
2022-04-13
FDA classified
2022-06-09
Posted by FDA
2022-06-15
Terminated
2023-11-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1055-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Ibuprofen · FDA Drug Recalls